SGLT2 inhibitors as the bedrock of therapy for heart failure.
Document Type
Article
Publication Date
9-3-2022
Publication Title
Lancet
Keywords
washington; spokane; pmrc; Diabetes Mellitus, Type 2; Heart Failure; Humans; Hypoglycemic Agents; Sodium-Glucose Transporter 2 Inhibitors
Clinical Institute
Kidney & Diabetes
Clinical Institute
Cardiovascular (Heart)
Department
Cardiology
Department
Endocrinology
Department
Nephrology
Recommended Citation
Tuttle, Katherine and Rangaswami, Janani, "SGLT2 inhibitors as the bedrock of therapy for heart failure." (2022). Articles, Abstracts, and Reports. 6449.
https://digitalcommons.providence.org/publications/6449
COinS
